PDF) The proto-oncogene Pim-1 is a target of miR-33a | Marshall Thomas - Academia.edu
Module III – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Mitarbeiter des Rudolf-Boehm-Institutes
Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects | Scientific Reports
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Foresee Edebi sanatlar yelken achim aigner leipzig university germany Tren istasyonu ilgisiz yerine getirmek
SiRNA-transfection of SKOV-3-Luc cells with the Biontex K2® Transfection System Dipl.-Chem. Alexander Ewe, Prof. Achim Aigner U
Perspectives, issues and solutions in RNAi therapy: the expected and the less expected
Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model
Mitarbeiter des Rudolf-Boehm-Institutes
Untersuchung der biologischen Aktivität von Nanopartikeln in Tumor- schnittkulturen
Let Life Sciences meet you Let Life Sciences meet you
Achim Aigner | Leipzig University, Germany | Pharmaceutica 2017 | Conferenceseries
Mitarbeiter des Rudolf-Boehm-Institutes
Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo
Mitarbeiter des Rudolf-Boehm-Institutes
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Multiple effects of the special ATâ•'rich binding protein 1 (SATB1) in colon carcinoma
Loop | Achim Aigner
Tetraspanin 5 (TSPAN5), a Novel Gatekeeper of the Tumor Suppressor DLC1 and Myocardin-Related Transcription Factors (MRTFs), Con
Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells
European Technology Platform on Nanomedicine
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Mitarbeiter des Rudolf-Boehm-Institutes
